Loading...
•
Dec 31, 2020
Cross Country Healthcare Q4 2020 Earnings Report
Announced financial results for the fourth quarter and full year 2020.
Key Takeaways
Cross Country Healthcare's Q4 2020 performance demonstrated its ability to deliver critical staff and support, with revenue at $215.6 million, flat year-over-year but up 11% sequentially, and net income attributable to common shareholders at $4.6 million, a significant improvement from prior periods.
Consolidated revenue for the fourth quarter was $215.6 million, representing an 11% sequential increase.
Consolidated gross margin was 25.2%, up 50 basis points year-over-year and sequentially.
Net income attributable to common shareholders was $4.6 million, a significant improvement from the prior year and quarter.
Adjusted EPS was $0.19, compared to $0.07 in the prior year.
Revenue by Segment
Forward Guidance
The company provided guidance for Q1 2021, anticipating revenue between $280 million and $295 million and adjusted EPS between $0.32 and $0.37.
Positive Outlook
- Sequential increases in bill rates
- Increase in the number of clinicians on COVID assignments
- Continued closures of schools in key markets
- Revenue between $280 million and $295 million
- Adjusted EPS between $0.32 and $0.37
Challenges Ahead
- High degree of uncertainty regarding the continued impact from COVID-19
- Potential impact of any future divestitures
- Potential impact of mergers, acquisitions or other business combinations
- Potential impact of changes in debt structure
- Potential impact of future share repurchases
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...